These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8360125)

  • 1. Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa.
    Asuquo AE; Piddock LJ
    J Antimicrob Chemother; 1993 Jun; 31(6):865-80. PubMed ID: 8360125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.
    Piddock LJ; Jin YF; Ricci V; Asuquo AE
    J Antimicrob Chemother; 1999 Jan; 43(1):61-70. PubMed ID: 10381102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
    Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T
    Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of quinolones resistance in Escherichia coli, Staphylococcus aureus and Pseudomonas areuginosa].
    Feng P; Yu R; Xia P; Lü X; Zhu S
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):501-4. PubMed ID: 12528531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.
    Denis A; Moreau NJ
    J Antimicrob Chemother; 1993 Sep; 32(3):379-92. PubMed ID: 8262860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
    Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
    Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of gemifloxacin and five other fluoroquinolones against defined isogenic mutants of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.
    Schulte A; Heisig P
    J Antimicrob Chemother; 2000 Dec; 46(6):1037-8. PubMed ID: 11102429
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between disc potency and zone size in temafloxacin activity in vitro.
    Reggio S; Bassanetti I; Ceralli M; Giardini R; Sansonetti G
    Drugs Exp Clin Res; 1990; 16(12):611-4. PubMed ID: 2130003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.
    McCaffrey C; Bertasso A; Pace J; Georgopapadakou NH
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1601-5. PubMed ID: 1416840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal action of PD127,391, an enhanced spectrum quinolone.
    Lewin CS; Amyes SG
    J Med Microbiol; 1990 Sep; 33(1):67-70. PubMed ID: 2231674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method.
    Tanaka M; Hoshino K; Hohmura M; Ishida H; Kitamura A; Sato K; Hayakawa I; Nishino T
    J Antimicrob Chemother; 1996 Jun; 37(6):1091-102. PubMed ID: 8836812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
    Biedenbach DJ; Jones RN;
    Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus.
    Piddock LJ; Jin YF; Griggs DJ
    J Antimicrob Chemother; 2001 Mar; 47(3):261-70. PubMed ID: 11222558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis and antibacterial activity of 5-amino-6, 8-difluoro-1-(5-fluoro-2-pyridyl)-7-(3-methyl-1-piperazinyl)-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues].
    Liu JY; Wei YG; Guo HY
    Yao Xue Xue Bao; 2001 Jun; 36(6):419-22. PubMed ID: 12585124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postantibiotic effects of E-4868 and OPC-17116.
    Sanford MD; Jones RN
    J Antimicrob Chemother; 1993 Dec; 32(6):916-7. PubMed ID: 8144440
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms and frequency of resistance to temafloxacin.
    Appelbaum PC
    Am J Med; 1991 Dec; 91(6A):27S-30S. PubMed ID: 1662892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of trovafloxacin (CP-99,219).
    Morrissey I
    J Antimicrob Chemother; 1996 Dec; 38(6):1061-6. PubMed ID: 9023654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.
    Morrissey I; Smith JT
    J Med Microbiol; 1995 Jul; 43(1):4-8. PubMed ID: 7608954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, antibacterial activities, and pharmacological properties of enantiomers of temafloxacin hydrochloride.
    Chu DT; Nordeen CW; Hardy DJ; Swanson RN; Giardina WJ; Pernet AG; Plattner JJ
    J Med Chem; 1991 Jan; 34(1):168-74. PubMed ID: 1846917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.